Harvey I. Pass is a board-certified general and thoracic surgeon acclaimed for his malignant pleural mesothelioma research efforts and clinical skills.
- Serves as chief of thoracic oncology at NYU Cancer Center, vice chair of research at NYU Health Center, and chief of the Thoracic Surgery Division at NYU Langone Medical Center.
- Co-founded Mesothelioma Applied Research Foundation and is its Scientific Advisory Board chairman.
- Career-long mesothelioma researcher who helped discover simian virus 40 in human mesothelioma along with the individual roles played by the neurofibromatosis gene and insulin growth factor receptor in triggering and sustaining mesothelioma.
- Oversees the Early Detection Research Network Biomarker Discovery Laboratory for Mesothelioma and the Clinical CORE component of the Mesothelioma Pathogenesis Program.
- Published a seminal New England Journal of Medicine paper documenting osteopontin as a sensitive and specific serum biomarker for mesothelioma.
- Helped edit several peer-reviewed periodicals including Journal of Thoracic Oncology, Clinical Lung Cancer, and Annals of Surgical Oncology; editorial board member of the Clinical Cancer Research.
- Reviewer for New England Journal of Medicine, Journal of the American Medical Association, International Journal of Cancer, and Journal of Clinical Oncology.
- Listed in “America’s Top Doctors.”
- M.D. degree from Duke University School of Medicine.